identified two HLA−A*0201 immunogenic epitopes of LDHC (LDHC41−55 and LDHC288−303), which increased interferon-γ (IFN-γ) secretion by CD8+ T cells and cancer cell killing of HLA-A*0201/LDHC-positive breast cancer cells (13). Here, HLA-A is linked to breast carcinoma.